No Sanctions For GSK, But Both Sides Told To 'Dial It Back'
GlaxoSmithKline will not face sanctions for a call to the U.S. Food and Drug Administration tied to multidistrict litigation over whether its anti-nausea medication Zofran causes birth defects, a Boston federal...To view the full article, register now.
Already a subscriber? Click here to view full article